Wednesday, September 9, 2026
spot_img

Transaction in Own Shares

ICG Enterprise Trust plc (the “Company”)

9 September 2026

Transaction in Own Shares

The Company announces that on 8 September 2026 it bought back 15,000 of its own shares, to be held as treasury shares, at an average price of 1466 pence per share.

Further details are set out below:

  • Number of shares held as treasury shares following settlement of this purchase: 2,969,402
  • Total shares in issue excluding treasury shares following settlement of this purchase: 60,584,790

The Company has bought back these shares under the authority granted by shareholders at its Annual General Meeting in June 2026, which permits the Company to repurchase a maximum of 14.99% of its ordinary shares. The actual number of shares repurchased by the Company will depend on market conditions. This authority lasts until the next shareholder authority granted (expected to be at the Annual General Meeting in 2027), or until expressly revoked by shareholders.

No maximum consideration payable has been determined by the Company, but the Company is unable to pay a price for any shares pursuant to the buyback which would equate to a premium to the net asset value. It is the Company’s current intention to hold any shares bought back in treasury.

The Company has instructed Numis Securities Limited (trading for these purposes as Deutsche Numis) as its broker in respect of its buyback transactions. This arrangement is in accordance with the UKLA Listing Rules and the Company’s general authority to repurchase shares.

Analyst / Investor enquiries:

Chris Hunt
Shareholder Relations, ICG
+44 (0) 20 3545 2020

Andrew Lewis
Company Secretary, ICG
+44 (0) 20 3545 1344

Media:

Clare Glynn
Corporate Communications, ICG
+44 (0) 20 3545 1395

Powered by SlickText.com

Hot this week

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Total Voting Rights and Transaction in Own Shares

9 September 2026 ICG plc (the “Company”) ...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

Topics

NBPE Announces Transaction in Own Shares

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION...

Total Voting Rights and Transaction in Own Shares

9 September 2026 ICG plc (the “Company”) ...

Pharming Group to participate in September investor conferences

Leiden, the Netherlands, September 9, 2026: Pharming Group N.V. (“Pharming”)...

GENFIT Highlights Long-Term Commercial Opportunity for its MASH Diagnostics Technology

Simple, reliable and scalable blood-based testing could identify patients...
spot_img

Related Articles

Popular Categories

spot_img